Henry Schein (NASDAQ: HSIC)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Henry Schein Returns vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Henry Schein Company Info
The Company is a distributor of healthcare products & services primarily to office-based healthcare practitioners in the combined North American & European markets. Conducts business through two segments; healthcare distribution & technology.
News & Analysis
Their financials could continue to get stronger this year.
See how these three stocks resisted the broader market's decline.
Earnings took down some key companies today.
A spinoff threw financial data sites for a loop today -- but not to worry. We'll clarify things for you.
That unit of the much-admired health care products and services company will then merge with another company in that space.
Stocks closed the day with modest gains, as Under Armour soared on strong international sales, and dental suppliers Henry Schein and Patterson Companies were dinged by antitrust allegations.
Shares are tumbling after news breaks that the U.S. government has filed a lawsuit against the company.
Shares tumbled after the company reported disappointing third-quarter earnings.
Valuation
Earnings Transcripts
HSIC earnings call for the period ending June 30, 2022.
HSIC earnings call for the period ending March 31, 2022.
HSIC earnings call for the period ending December 31, 2021.
HSIC earnings call for the period ending September 30, 2021.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.